IHS Chemical Week

People & Business :: Earnings/Finance

Lanxess to revise strategy after sales and earnings plummet; 2014 target unrealistic

1:54 AM MDT | August 6, 2013 | Natasha Alperowicz

Lanxess today reported a 95% decline in second-quarter net income to €9 million ($11.9 million) on sales down 12% to €2.1 billion. Second-quarter Ebitda was down 45% at €198 million, corresponding to the company’s “middle of the guided range.” In its outlook Lanxess says 2013 Ebitda pre-exceptionals is likely to be €700 million-800 million, compared with the May guidance of “less than €1 billion”. The company says that the earlier reported 2014 Ebitda pre-exceptionals target for 2014 of €1.4 billion is...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa